At the small community hospital I work at, I fought to get a neutral valve injection cap into the hospital since there has been a push to move away from heplock flushes. But since its introduction our central line infection rate has jumped considerably even with the introduction of pre-filled saline flush syringes during the year. We still use heplock for most patients but not for patients with low platelet counts and with HIT.
I met with the vendor who assures me it couldn't possibly be his product. We now are changing the injection caps twice weekly instead of Q 7days with dressing changes and are using direct -connect w/ patients receiving TPN.( The highest risk factor that was identified). We have been using the biopatch for years on all of our central lines including PICC's.
What would be the best way to determine if it is indeed the injection cap that is the culprit or should I start shopping around for a split septum product and just assume it is the injection cap?
I too based my decision on the Ryder study.
Kathy Cutter, CRNI